Biological Safety Testing Market
According to Intent Market Research, the Biological Safety Testing Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 20.9% to touch USD 5.6 billion by 2030. The Biological Safety Testing Market is dominated by key players such as Charles River Laboratories, Lonza Group AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., SGS S.A., Eurofins Scientific, WuXi AppTec, Bio-Rad Laboratories, Inc., Toxikon Corporation, Cytovance Biologics, Avance Biosciences Inc., Paragon Bioservices (Catalent), Pacific BioLabs, Nelson Labs.